A novel prognostic model predicts overall survival in colon cancer based on RNA splicing regulation gene expression

Qiu‐Yun Luo,Tian Di,Zhi‐Gang Chen,Jian‐Hong Peng,Jian Sun,Zeng‐Fei Xia,Wen‐Tao Pan,Fan Luo,Fei‐Teng Lu,Yu‐Ting Sun,Li‐Qiong Yang,Lin Zhang,Da‐Jun Yang,Qiu Miao‐Zhen
DOI: https://doi.org/10.1111/cas.15480
IF: 5.7
2022-07-11
Cancer Science
Abstract:Colon cancer is the third most common cancer and the second leading cause of cancer related death. Dysregulated RNA splicing factors have been reported to be associated with tumorigenesis and development in colon cancer. In this study, we interrogated clinical and RNA expression data of colon cancer patients from The Cancer Genome Atlas (TCGA) dataset and the Gene Expression Omnibus (GEO) database. Genes regulating RNA splicing correlated with survival in colon cancer were identified and constructed a risk score model using Cox regression analyses. In the risk model, RNA splicing factor PPARGC1 is correlated with a good survival outcome while CLK1, CLK2 and AKAP8L with a bad survival outcome. The risk model has a good performance for clinical prognostic prediction both in TCGA cohort and other two validation cohorts. In tumor micro‐environment (TME) analysis, the immune score was higher in low risk group, and TME related pathway gene expression were also higher in low risk group. We further verified the mRNA and protein expression levels of these four genes in the adjacent nontumor, tumor and liver metastasis tissues of colon cancer patients, which were consistent with bioinformatics analysis. In addition, knockdown of AKAP8L can suppress the proliferation and migration of colon cancer cell. Animal studies have also shown that AKAP8L knockdown can inhibit tumor growth in colon cancer in vivo. We established a prognostic risk model for colon cancer based on genes related to RNA splicing regulation and uncovered the role of AKAP8L in promoting colon cancer progression.
oncology
What problem does this paper attempt to address?